$DHAI
DIH HOLDING US, INC.

2022 Q3 Form 10-Q Financial Statement

#000119312522284594 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2021 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses -$1.374M
YoY Change
Operating Profit -$219.3K -$9.947K
YoY Change 2104.99%
Interest Expense $1.374M
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.374M
YoY Change
Pretax Income $1.155M
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $1.155M -$9.947K
YoY Change -11709.98%
Net Earnings / Revenue
Basic Earnings Per Share $0.05 $0.00
Diluted Earnings Per Share $0.05 $0.00
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $257.1K
YoY Change
Cash & Equivalents $257.1K
Short-Term Investments
Other Short-Term Assets $432.1K
YoY Change
Inventory
Prepaid Expenses $432.1K
Receivables
Other Receivables
Total Short-Term Assets $689.2K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $205.2M
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $205.2M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $689.2K
Total Long-Term Assets $205.2M
Total Assets $205.9M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $91.22K
YoY Change
Accrued Expenses $64.51K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $155.7K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $7.603M
YoY Change
Total Long-Term Liabilities $7.603M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $155.7K
Total Long-Term Liabilities $7.603M
Total Liabilities $7.759M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$7.070M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$7.070M $15.05K
YoY Change
Total Liabilities & Shareholders Equity $205.9M
YoY Change

Cashflow Statement

Concept 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income $1.155M -$9.947K
YoY Change -11709.98%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$134.0K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -134.0K
Cash From Investing Activities 0.000
Cash From Financing Activities 0.000
Net Change In Cash -134.0K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$134.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001883788
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41250
dei Entity Registrant Name
EntityRegistrantName
AURORA TECHNOLOGY ACQUISITION CORP
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1624542
dei Entity Address Address Line1
EntityAddressAddressLine1
4 Embarcadero Center
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1449
dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94105
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
550-0458
dei Security12b Title
Security12bTitle
Class A Ordinary Share, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
ATAK
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q3 us-gaap Cash
Cash
257120
CY2021Q4 us-gaap Cash
Cash
65373
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
432070
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0
CY2022Q3 us-gaap Assets Current
AssetsCurrent
689190
CY2021Q4 us-gaap Assets Current
AssetsCurrent
65373
CY2022Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
205175816
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
0
CY2022Q3 us-gaap Deferred Costs
DeferredCosts
0
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
307402
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
205175816
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
307402
CY2022Q3 us-gaap Assets
Assets
205865006
CY2021Q4 us-gaap Assets
Assets
372775
CY2021Q4 atak Accrued Offering Costs
AccruedOfferingCosts
104990
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
91222
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9947
CY2022Q3 atak Accrued Offering Costs
AccruedOfferingCosts
64512
CY2022Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
242801
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
155734
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
357738
CY2022Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
533000
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0
CY2022Q3 atak Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
7070000
CY2021Q4 atak Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
0
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
7603000
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0
CY2022Q3 us-gaap Liabilities
Liabilities
7758734
CY2021Q4 us-gaap Liabilities
Liabilities
357738
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
205175816
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24425
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7070079
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9963
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-7069544
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15037
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
205865006
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
372775
CY2022Q3 atak Formation And Operating Costs
FormationAndOperatingCosts
219330
atak Formation And Operating Costs
FormationAndOperatingCosts
1210401
CY2021Q3 atak Formation And Operating Costs
FormationAndOperatingCosts
9947
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-219330
us-gaap Operating Income Loss
OperatingIncomeLoss
-1210401
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9947
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-471500
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5247547
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
258440
CY2022Q3 us-gaap Investment Income Dividend
InvestmentIncomeDividend
902675
us-gaap Investment Income Dividend
InvestmentIncomeDividend
1155816
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
-1374175
us-gaap Operating Expenses
OperatingExpenses
-6661803
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1154845
us-gaap Net Income Loss
NetIncomeLoss
5451402
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-9947
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15037
CY2022Q1 atak Remeasurement Of Redemption Value
RemeasurementOfRedemptionValue
-30006587
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
0
CY2022Q1 atak Stock Issued During Period Representative Shares Issued Value
StockIssuedDuringPeriodRepresentativeSharesIssuedValue
3030000
CY2022Q1 atak Rights Underlying The Units Value
RightsUnderlyingTheUnitsValue
15596420
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3097637
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-8267493
CY2022Q2 atak Remeasurement Of Redemption Value
RemeasurementOfRedemptionValue
-253141
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1198920
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-7321714
CY2022Q3 atak Remeasurement Of Redemption Value
RemeasurementOfRedemptionValue
-902675
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1154845
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-7069544
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
0
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-9947
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
15053
us-gaap Net Income Loss
NetIncomeLoss
5451402
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-9947
atak Allocation Of Deferred Offering Costs For Warrant Liability
AllocationOfDeferredOfferingCostsForWarrantLiability
516746
CY2021Q3 atak Allocation Of Deferred Offering Costs For Warrant Liability
AllocationOfDeferredOfferingCostsForWarrantLiability
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-5247547
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
258440
us-gaap Investment Income Dividend
InvestmentIncomeDividend
1155816
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
432070
atak Increase Decrease In Accounts Payable And Accrued Expenses
IncreaseDecreaseInAccountsPayableAndAccruedExpenses
81275
CY2021Q3 atak Increase Decrease In Accounts Payable And Accrued Expenses
IncreaseDecreaseInAccountsPayableAndAccruedExpenses
9947
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1044450
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
204020000
CY2021Q3 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-204020000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
202000000
CY2021Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
atak Payment Of Underwriting Fee
PaymentOfUnderwritingFee
2525000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6470000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
242801
CY2021Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
atak Payment Of Offering Costs
PaymentOfOfferingCosts
446002
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
205256197
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
191747
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65373
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
257120
atak Initial Measurement Of Classa Ordinary Shares Subject To Possible Redemption
InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption
174013413
atak Initial Measurement Of Public Warrants And Private Placement Warrants
InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants
5780547
CY2021Q3 atak Initial Measurement Of Public Warrants And Private Placement Warrants
InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants
atak Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
7070000
atak Remeasurement Of Class A Ordinary Shares Subject To Possible Redemption
RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption
31162403
CY2021Q3 atak Remeasurement Of Class A Ordinary Shares Subject To Possible Redemption
RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption
atak Forfeiture Of Founder Shares
ForfeitureOfFounderShares
-70
atak Stock Issued During Period Representative Shares Issued Value Class A
StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA
30
atak Deferred Offering Costs Incurred Included In Accrued Offering Costs
DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts
64512
CY2021Q3 atak Deferred Offering Costs Incurred Included In Accrued Offering Costs
DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts
49156
CY2021Q3 atak Non Cash Borrowings Against Promissory Note
NonCashBorrowingsAgainstPromissoryNote
25000
CY2021Q3 us-gaap Stock Issued1
StockIssued1
25000
CY2022Q1 atak Overallotment Option Liability
OverallotmentOptionLiability
258440
CY2022Q1 atak Stock Issued During Period Representative Shares Issued Value
StockIssuedDuringPeriodRepresentativeSharesIssuedValue
3030000
CY2022Q1 atak Rights Underlying The Units Value
RightsUnderlyingTheUnitsValue
15596420
CY2022Q3 atak Percentage Of Fair Market Value Of Target Business To Asset Held In Trust Account
PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount
80
CY2022Q3 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001
atak Number Of Days Within Which Public Shares Shall Be Redeemed
NumberOfDaysWithinWhichPublicSharesShallBeRedeemed
P10D
CY2022Q3 us-gaap Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities
LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities
50000
CY2022Q3 atak Operating Cash
OperatingCash
257120
CY2021Q4 atak Operating Cash
OperatingCash
65373
CY2022Q3 atak Net Working Capital Surplus Deficit
NetWorkingCapitalSurplusDeficit
533456
CY2021Q4 atak Net Working Capital Surplus Deficit
NetWorkingCapitalSurplusDeficit
-292365
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available. Accordingly, the actual results could differ significantly from those estimates. </div></div>
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q3 atak Percentage Of Public Shares To Be Redeemed In Case Business Combination Is Not Consummated
PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated
1
CY2022Q1 atak Stock Issued During Period Representative Shares Issued Value
StockIssuedDuringPeriodRepresentativeSharesIssuedValue
3030000
CY2022Q1 atak Rights Underlying The Units Value
RightsUnderlyingTheUnitsValue
15596420
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. </div></div>
CY2022Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
533000
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
0
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
26670000
atak Minimum Lock In Period For Transfer Assign Or Sell Warrants After Completion Of Ipo
MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo
P30D

Files In Submission

Name View Source Status
0001193125-22-284594-index-headers.html Edgar Link pending
0001193125-22-284594-index.html Edgar Link pending
0001193125-22-284594.txt Edgar Link pending
0001193125-22-284594-xbrl.zip Edgar Link pending
atak-20220930.xsd Edgar Link pending
d408426d10q.htm Edgar Link pending
d408426dex311.htm Edgar Link pending
d408426dex312.htm Edgar Link pending
d408426dex321.htm Edgar Link pending
d408426dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
atak-20220930_cal.xml Edgar Link unprocessable
atak-20220930_lab.xml Edgar Link unprocessable
atak-20220930_def.xml Edgar Link unprocessable
atak-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
d408426d10q_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending